SK159599A3 - New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy - Google Patents
New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy Download PDFInfo
- Publication number
- SK159599A3 SK159599A3 SK1595-99A SK159599A SK159599A3 SK 159599 A3 SK159599 A3 SK 159599A3 SK 159599 A SK159599 A SK 159599A SK 159599 A3 SK159599 A3 SK 159599A3
- Authority
- SK
- Slovakia
- Prior art keywords
- nabpc157
- disorders
- salt
- pro
- leu
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97108384 | 1997-05-23 | ||
| PCT/EP1998/002953 WO1998052973A1 (en) | 1997-05-23 | 1998-05-20 | New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK159599A3 true SK159599A3 (en) | 2000-11-07 |
Family
ID=8226822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1595-99A SK159599A3 (en) | 1997-05-23 | 1998-05-20 | New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6288028B1 (cs) |
| EP (1) | EP0983300B1 (cs) |
| JP (1) | JP3492381B2 (cs) |
| KR (1) | KR100488038B1 (cs) |
| CN (1) | CN1166683C (cs) |
| AR (1) | AR011478A1 (cs) |
| AT (1) | ATE277948T1 (cs) |
| AU (1) | AU731317B2 (cs) |
| BG (1) | BG64023B1 (cs) |
| BR (1) | BR9809457B1 (cs) |
| CA (1) | CA2290739C (cs) |
| CZ (1) | CZ299423B6 (cs) |
| DE (1) | DE69826653T2 (cs) |
| DK (1) | DK0983300T3 (cs) |
| EA (1) | EA002058B1 (cs) |
| ES (1) | ES2229507T3 (cs) |
| HU (1) | HU227800B1 (cs) |
| ID (1) | ID23184A (cs) |
| IL (2) | IL132884A0 (cs) |
| NO (1) | NO321126B1 (cs) |
| NZ (1) | NZ501323A (cs) |
| PL (1) | PL193790B1 (cs) |
| PT (1) | PT983300E (cs) |
| RS (1) | RS49733B (cs) |
| SK (1) | SK159599A3 (cs) |
| TR (1) | TR199902866T2 (cs) |
| UA (1) | UA61955C2 (cs) |
| WO (1) | WO1998052973A1 (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070160697A1 (en) * | 2004-02-27 | 2007-07-12 | Hiroshi Kobayashi | Cancer metastasis inhibitory composition |
| US8022216B2 (en) * | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| SI24318A (sl) * | 2013-03-13 | 2014-09-30 | Diagen D.O.O. | Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji |
| US10350293B2 (en) | 2016-08-23 | 2019-07-16 | Pharmacotherapia d.o.o. | Compositions and methods for treating symptoms associated with multiple sclerosis |
| SG11202000940XA (en) | 2017-08-24 | 2020-02-27 | Novo Nordisk As | Glp-1 compositions and uses thereof |
| CA3165359A1 (en) | 2020-02-18 | 2021-07-22 | Dorthe Kot Engelund | Glp-1 compositions and uses thereof |
| US11065298B1 (en) * | 2020-04-24 | 2021-07-20 | Chanda Zaveri | Compositions and methods for treating or preventing viral infections |
| US11833189B1 (en) * | 2023-05-15 | 2023-12-05 | Red Mountain Med Spa, LLC | Sublingual Semaglutide-BPC 157 combination for weight loss |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992004368A1 (en) * | 1990-09-11 | 1992-03-19 | Sikiric Predrag | Pharmacologically active substance bpc, the process for its preparation and its use in the therapy |
| ATE152734T1 (de) * | 1992-05-30 | 1997-05-15 | Sikiric Predrag | Bpc-peptide, deren herstellung und verwendung |
| ATE163131T1 (de) | 1992-11-16 | 1998-02-15 | Petek Marijan | Bpc-peptide, deren herstellung und therapeutischen verwendung |
-
1998
- 1998-05-20 WO PCT/EP1998/002953 patent/WO1998052973A1/en active IP Right Grant
- 1998-05-20 BR BRPI9809457-2A patent/BR9809457B1/pt not_active IP Right Cessation
- 1998-05-20 IL IL13288498A patent/IL132884A0/xx active IP Right Grant
- 1998-05-20 EA EA199901061A patent/EA002058B1/ru not_active IP Right Cessation
- 1998-05-20 CA CA002290739A patent/CA2290739C/en not_active Expired - Fee Related
- 1998-05-20 ID IDW991444A patent/ID23184A/id unknown
- 1998-05-20 RS YUP-601/99A patent/RS49733B/sr unknown
- 1998-05-20 TR TR1999/02866T patent/TR199902866T2/xx unknown
- 1998-05-20 NZ NZ501323A patent/NZ501323A/en not_active IP Right Cessation
- 1998-05-20 KR KR10-1999-7010862A patent/KR100488038B1/ko not_active IP Right Cessation
- 1998-05-20 EP EP98929345A patent/EP0983300B1/en not_active Expired - Lifetime
- 1998-05-20 UA UA99127002A patent/UA61955C2/uk unknown
- 1998-05-20 PL PL98336897A patent/PL193790B1/pl unknown
- 1998-05-20 ES ES98929345T patent/ES2229507T3/es not_active Expired - Lifetime
- 1998-05-20 DE DE69826653T patent/DE69826653T2/de not_active Expired - Lifetime
- 1998-05-20 SK SK1595-99A patent/SK159599A3/sk unknown
- 1998-05-20 DK DK98929345T patent/DK0983300T3/da active
- 1998-05-20 CZ CZ0414299A patent/CZ299423B6/cs not_active IP Right Cessation
- 1998-05-20 AU AU79141/98A patent/AU731317B2/en not_active Ceased
- 1998-05-20 JP JP54994898A patent/JP3492381B2/ja not_active Expired - Fee Related
- 1998-05-20 AT AT98929345T patent/ATE277948T1/de active
- 1998-05-20 CN CNB988053934A patent/CN1166683C/zh not_active Expired - Fee Related
- 1998-05-20 PT PT98929345T patent/PT983300E/pt unknown
- 1998-05-20 HU HU0002329A patent/HU227800B1/hu not_active IP Right Cessation
- 1998-05-20 US US09/424,414 patent/US6288028B1/en not_active Expired - Lifetime
- 1998-05-26 AR ARP980102425A patent/AR011478A1/es active IP Right Grant
-
1999
- 1999-11-11 IL IL132884A patent/IL132884A/en not_active IP Right Cessation
- 1999-11-19 NO NO19995692A patent/NO321126B1/no not_active IP Right Cessation
- 1999-11-19 BG BG103905A patent/BG64023B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101476451B1 (ko) | 자가면역성 질환의 치료 | |
| SK42398A3 (en) | Application of r'-glu-trp-r''dipeptide for the treatment of neovascularization | |
| MX2013013198A (es) | Combinacion farmaceutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2. | |
| MX2013013200A (es) | Combinación farmacéutica para uso en la inducción de pérdida de peso en pacientes que padecen diabetes de tipo 2 y/o en la prevención del aumento de peso en pacientes que padecen diabetes de tipo 2. | |
| KR20190116416A (ko) | 원발 담즙성 담관염을 치료하기 위한 화합물 및 방법 | |
| US5482930A (en) | Anti-inflammatory composition and method with des-Tyr dynorphin and analogues | |
| US7645733B2 (en) | Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions | |
| EP0983300B1 (en) | Bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy | |
| JP6217053B2 (ja) | 新規安定性ペンタデカペプチド塩、その製造方法、医薬製剤の製造におけるその使用及び治療におけるその使用 | |
| CN107540726A (zh) | 一类肽基塞来昔布衍生物及其应用 | |
| LT5421B (lt) | Tetrapeptidas, reguliuojantis kraujo gliukozės lygį, sergant cukriniu diabetu | |
| FI92391C (fi) | Menetelmä 3-(N-fenyyliasetyyliaminopiperidiini)-2,6-dionin valmistamiseksi | |
| MXPA99010804A (en) | New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy | |
| US20060166890A1 (en) | Non-t cell binding peptides and their uses | |
| RU2717674C1 (ru) | Лекарственное средство, усиливающее оксигенацию тканей при диабетической стопе, и способ его применения | |
| HRP20010006A2 (en) | New peptide salts with organo-protective activity, the process for their preparation and their use in therapy | |
| WO2006047948A1 (en) | The use of human urinary kallidinogenase for the manufacture of a medicine for the treatment of sepsis |